Image

Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer

Recruiting
18 years and older
Both
Phase N/A
  • Simplified (AI rewritten)
  • Technical (Original)

Stereotactic Ablative Radiotherapy (SABR) is a special type of radiation treatment that targets cancer in a precise way. This study looks at how effective SABR is for treating a type of lung cancer called non-small cell lung cancer (NSCLC), which has spread to a few other places in the body, called oligo-metastatic disease. When cancer spreads to 1-5 places soon after the main cancer is found, it's called synchronous; if it spreads later, it's metachronous. SABR can help manage these spots and improve survival without making patients feel worse. Patients in this study may also get targeted therapies (special drugs that attack cancer cells) or immunotherapy (treatments that help the immune system fight cancer).

  • The study lasts for about 4-6 months.
  • Participants may receive SABR alone or combined with other therapies.
  • There are no high-grade side effects expected, but pregnant women cannot participate.
Print
Study details
    NSCLC
    NSCLC Stage IV
    Oligometastatic Disease
    Non Small Cell Lung Cancer
    Non Small Cell Lung Cancer Metastatic
    EGF-R Positive Non-Small Cell Lung Cancer
    NSCLC Stage IV Without EGFR/ALK Mutation
    Non-Small Cell Adenocarcinoma
    Non-Small Cell Squamous Lung Cancer
    Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
    Synchronous Metastases
    Metachronous Metastasis

NCT06207292

Radiotherapy Oncology Centre "Santa Maria" Hospital

24 January 2024

Contact a study center
Not finding the right Trial?

You can also call our Patient navigators who can help you to find the right trial.

Call now
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.